Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
05 Jun 2025$BW soared an incredible 66.9%, fueled by news that Babcock & Wilcox is selling its Diamond Power International unit in a $177 million deal, signaling a strategic pivot. Adding fuel to the fire, the company also launched a $70 million cash tender offer for its 2026 senior notes, showing strong financial management and a confident capital structure cleanup. With the UK’s defense industry ramping up, Babcock & Wilcox appears poised to benefit significantly, making it one of the day’s hottest plays.
$PL jumped nearly 50%, riding a wave of excitement after posting an earnings beat with record revenue. Planet Labs satellite imaging business impressed investors, backed by strong guidance projecting $265 million to $280 million in revenue by fiscal 2026. The company’s expanding market presence and AI-enhanced satellite solutions earned a bullish nod from Wedbush, who raised its price target to $7. This combination of solid fundamentals and growth potential kept traders flocking to $PL.
$IINN gained 25% as Inspira Technologies scaled up production for its ART100 system amid advanced negotiations with a European government authority. The company’s commitment to fast-tracking global rollout of its life-saving blood sensor technology, alongside development of next-gen platforms like ART500 and HYLA™, adds momentum and intrigue for investors watching healthcare innovation closely.
$IMAB climbed nearly 28% with a spotlight on its upcoming presentation at the Jefferies Global Healthcare Conference. As investors anticipate fresh updates and strategic insights, I-Mab’s biotech focus keeps it in the spotlight for those seeking exposure to promising healthcare breakthroughs.
$SATS rebounded by 17.5%, bouncing back on renewed investor interest driven by positive market sentiment around EchoStar’s growth prospects and improving fundamentals.
June 20, 2025 09:47 AM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
